According to Alembic Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.35.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 3.34 | 54.25% |
2022-12-31 | 2.17 | -29.67% |
2021-12-31 | 3.08 | -31.94% |
2020-12-31 | 4.52 | 25.85% |
2019-12-31 | 3.60 | -25.08% |
2018-12-31 | 4.80 | -6.2% |
2017-12-31 | 5.12 | -20.49% |
2016-12-31 | 6.44 | -38.65% |
2015-12-31 | 10.5 | 4.92% |
2014-12-31 | 10.00 | 53.21% |
2013-12-31 | 6.53 | 362.84% |
2012-12-31 | 1.41 |